Platelet ADP receptor inhibitors

Details for Australian Patent Application No. 2001236644 (hide)

Owner Portola Pharmaceuticals, Inc.

Inventors Jantzen, Hans-Michael; Sedlock, David M.; Huang, Wolin; Scarborough Jr., Robert M.; Marlowe, Charles K.

Agent Spruson & Ferguson

Pub. Number AU-B-2001236644

PCT Pub. Number WO01/57037

Priority 60230447 06.09.00 US; 60180208 04.02.00 US; 60202072 05.05.00 US

Filing date 5 February 2001

Wipo publication date 14 August 2001

Acceptance publication date 4 May 2006

International Classifications

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 239/22 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/50 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 333/34 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

1 September 2005 Assignment before Grant

  Millennium Pharmaceuticals, Inc. The application has been assigned to Portola Pharmaceuticals, Inc.

4 May 2006 Application Accepted

  Published as AU-B-2001236644

6 July 2006 Corrigenda

  Applications Accepted - Name Index Under the name Portola Pharmaceuticals, Inc., Application No. 2001236644, under INID (72) correct the co-inventor to read Scarborough, Robert M.

28 September 2006 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 15 Aug 2006. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

28 September 2006 Standard Patent Sealed

22 February 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 15 Aug 2006

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001236645-Interference fit support bracket for a portable folding chair

2001236643